65 related articles for article (PubMed ID: 2195454)
1. [Post-antibiotic effect of imipenem, amikacin and ciprofloxacin against various strains of Serratia marcescens].
Bollet C; Mallet MN; Bouchemal H; de Micco P
Pathol Biol (Paris); 1990 May; 38(5):446-9. PubMed ID: 2195454
[TBL] [Abstract][Full Text] [Related]
2. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
[TBL] [Abstract][Full Text] [Related]
3. Effect of suprainhibitory concentrations of quinolones on hydrophobicity and motility of Serratia marcescens.
Majtán V; Majtánová L
Microbios; 2000; 102(402):79-88. PubMed ID: 10885498
[TBL] [Abstract][Full Text] [Related]
4. [Effect of superinhibitory levels of imipenem and amikacin singly or in combination on Pseudomonas aeruginosa].
Hostacká A
Epidemiol Mikrobiol Imunol; 1997 Dec; 46(4):155-7. PubMed ID: 9471306
[TBL] [Abstract][Full Text] [Related]
5. Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Kentepozidis N; Antonopoulou A; Plachouras D; Tsaganos T; Giamarellou H
Diagn Microbiol Infect Dis; 2005 Feb; 51(2):113-7. PubMed ID: 15698716
[TBL] [Abstract][Full Text] [Related]
6. The postantibiotic effect of amikacin alone and in combination with piperacillin on gram-negative bacteria.
Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
Scand J Infect Dis Suppl; 1990; 74():129-32. PubMed ID: 2129064
[TBL] [Abstract][Full Text] [Related]
7. [Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
Młynarczyk G; Młynarczyk A; Pupek J; Bilewska A; Luczak M
Med Dosw Mikrobiol; 2007; 59(1):35-42. PubMed ID: 17601029
[TBL] [Abstract][Full Text] [Related]
8. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
Chin NX; Neu HC
Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin.
Gould IM; Milne K; Jason C
Drugs Exp Clin Res; 1990; 16(12):621-8. PubMed ID: 2130004
[TBL] [Abstract][Full Text] [Related]
10. Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains.
Wojnicz D; Jankowski S
Int J Antimicrob Agents; 2007 Jun; 29(6):700-4. PubMed ID: 17382520
[TBL] [Abstract][Full Text] [Related]
11. Compatible results obtained from biotyping and serotyping in Serratia marcescens.
Grimont PA; Grimont F; Le Minor S; Davis B; Pigache F
J Clin Microbiol; 1979 Oct; 10(4):425-32. PubMed ID: 393712
[TBL] [Abstract][Full Text] [Related]
12. The postantibiotic effect of meropenem and imipenem on selected bacteria.
Nadler HL; Pitkin DH; Sheikh W
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J
Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430
[TBL] [Abstract][Full Text] [Related]
14. [Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
Chevalier B; Cavallo JD; Meyran M
Pathol Biol (Paris); 1995 Apr; 43(4):264-9. PubMed ID: 7567112
[TBL] [Abstract][Full Text] [Related]
15. Synergic post-antibiotic effect of amikacin in combination with beta-lactam antibiotics on gram-negative bacteria.
Isaksson B; Hanberger H; Maller R; Nilsson LE; Nilsson M
J Antimicrob Chemother; 1991 Jul; 28(1):25-34. PubMed ID: 1769941
[TBL] [Abstract][Full Text] [Related]
16. [Optimization of antibiotics in combination].
Zhang LH; Wang LF; Meng ZY; Yu QP; Gao BQ; Ba T; Wang XD; Ma WH; Li YY; Zhang J
Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):93-6. PubMed ID: 18785405
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
Moody JA; Gerding DN; Peterson LR
Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro.
Kim SY; Lim JA; Choi JS; Choi EC; Joo CK
Cornea; 2007 Jul; 26(6):720-5. PubMed ID: 17592324
[TBL] [Abstract][Full Text] [Related]
19. Post-antibiotic effect in Bacteroides fragilis group.
Siverhus DJ; Edmiston CE; Clausz JC; Goheen MP
Ann Clin Lab Sci; 1988; 18(4):326-36. PubMed ID: 3165611
[TBL] [Abstract][Full Text] [Related]
20. Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates.
Yu WL; Lin CW; Wang DY
J Microbiol Immunol Infect; 1998 Sep; 31(3):171-9. PubMed ID: 10496154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
